SPATA32
geneOn this page
Also known as FLJ25414AEP2VAD1.2
Summary
SPATA32 (spermatogenesis associated 32, HGNC:26349) is a protein-coding gene on chromosome 17q21.31, encoding Spermatogenesis-associated protein 32 (Q96LK8).
Predicted to enable actin binding activity. Predicted to be involved in spermatogenesis. Predicted to be active in perinuclear region of cytoplasm.
Source: NCBI Gene 124783 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_152343
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26349 |
| Approved symbol | SPATA32 |
| Name | spermatogenesis associated 32 |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ25414, AEP2, VAD1.2 |
| Ensembl gene | ENSG00000184361 |
| Ensembl biotype | protein_coding |
| Entrez | 124783 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 nonsense_mediated_decay, 1 protein_coding
ENST00000331780, ENST00000586359, ENST00000588866
RefSeq mRNA: 1 — MANE Select: NM_152343
NM_152343
CCDS: CCDS32669
Canonical transcript exons
ENST00000331780 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003596316 | 45255115 | 45256073 |
| ENSE00003611730 | 45257153 | 45257207 |
| ENSE00003643586 | 45262004 | 45262094 |
| ENSE00003657149 | 45254393 | 45254513 |
| ENSE00003676387 | 45256376 | 45256415 |
Expression profiles
Bgee: expression breadth broad, 79 present calls, max score 94.65.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1297 / max 109.1626, expressed in 12 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166532 | 0.1211 | 12 |
| 166533 | 0.0086 | 3 |
Top tissues by expression
161 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of paranasal sinus | UBERON:0005030 | 94.65 | silver quality |
| left testis | UBERON:0004533 | 92.09 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 92.04 | gold quality |
| cardia of stomach | UBERON:0001162 | 91.59 | silver quality |
| right testis | UBERON:0004534 | 91.47 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 91.14 | silver quality |
| substantia nigra pars reticulata | UBERON:0001966 | 91.06 | silver quality |
| sperm | CL:0000019 | 90.91 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 90.07 | silver quality |
| epithelium of nasopharynx | UBERON:0001951 | 89.96 | gold quality |
| vena cava | UBERON:0004087 | 89.74 | silver quality |
| testis | UBERON:0000473 | 89.36 | gold quality |
| ventral tegmental area | UBERON:0002691 | 89.26 | silver quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 89.19 | silver quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 88.16 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 87.36 | gold quality |
| pericardium | UBERON:0002407 | 87.12 | silver quality |
| pons | UBERON:0000988 | 87.06 | gold quality |
| saphenous vein | UBERON:0007318 | 86.85 | gold quality |
| superficial temporal artery | UBERON:0001614 | 86.77 | gold quality |
| trachea | UBERON:0003126 | 86.77 | gold quality |
| renal medulla | UBERON:0000362 | 86.14 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 86.00 | silver quality |
| biceps brachii | UBERON:0001507 | 85.37 | gold quality |
| deltoid | UBERON:0001476 | 85.25 | silver quality |
| mammary duct | UBERON:0001765 | 85.11 | gold quality |
| nipple | UBERON:0002030 | 85.07 | gold quality |
| cerebellar vermis | UBERON:0004720 | 84.80 | silver quality |
| thymus | UBERON:0002370 | 84.49 | silver quality |
| synovial joint | UBERON:0002217 | 84.47 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.71 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Spata32 | ENSMUSG00000044787 |
| rattus_norvegicus | Spata32 | ENSRNOG00000003275 |
Protein
Protein identifiers
Spermatogenesis-associated protein 32 — Q96LK8 (reviewed: Q96LK8)
Alternative names: Testis-expressed protein 34
All UniProt accessions (3): K7EPE1, K7EQM9, Q96LK8
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Interacts with syntaxin-1 and ACTB.
Tissue specificity. Detected in testis, and on the acrosomal cap of spermatids.
RefSeq proteins (1): NP_689556* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029297 | SPATA32 | Family |
Pfam: PF15310
UniProt features (19 total): sequence conflict 9, region of interest 4, compositionally biased region 2, modified residue 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96LK8-F1 | 42.23 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 167, 170
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 23 (showing top):
TGACCTY_ERR1_Q2, GOBP_MALE_GAMETE_GENERATION, ATF1_Q6, GATA1_01, LXR_Q3, GOMF_ACTIN_BINDING, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOMF_CYTOSKELETAL_PROTEIN_BINDING, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MTF1_Q4, GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP, SETD7_TARGET_GENES, DR4_Q2, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN, GOBP_SEXUAL_REPRODUCTION
GO Biological Process (1): spermatogenesis (GO:0007283)
GO Molecular Function (2): actin binding (GO:0003779), protein binding (GO:0005515)
GO Cellular Component (1): perinuclear region of cytoplasm (GO:0048471)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cytoskeletal protein binding | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
653 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPATA32 | SPATA31A7 | Q8IWB4 | 855 |
| SPATA32 | KRTAP24-1 | Q3LI83 | 574 |
| SPATA32 | KIAA1328 | Q86T90 | 567 |
| SPATA32 | TMEM126B | Q8IUX1 | 491 |
| SPATA32 | CATSPER1 | Q8NEC5 | 469 |
| SPATA32 | TEX11 | Q8IYF3 | 461 |
| SPATA32 | DCAKD | Q8WVC6 | 445 |
| SPATA32 | NDUFA10 | O95299 | 435 |
| SPATA32 | PARP9 | Q8IXQ6 | 422 |
| SPATA32 | PANX1 | Q96RD7 | 419 |
| SPATA32 | REC8 | O95072 | 418 |
| SPATA32 | PCNT | O95613 | 398 |
| SPATA32 | HLA-DPA1 | P01905 | 393 |
| SPATA32 | ARHGAP27 | Q6ZUM4 | 380 |
| SPATA32 | IL4R | P24394 | 369 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PIK3R3 | SPATA32 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NTAQ1 | SPATA32 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NTAQ1 | SPATA32 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PIK3R3 | SPATA32 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (5): SPATA32 (Two-hybrid), SPATA32 (Two-hybrid), SPATA32 (Affinity Capture-MS), SPATA32 (Affinity Capture-MS), SPATA32 (Protein-peptide)
ESM2 similar proteins: A0A1L8I316, A0A1W2PR82, A0A286YDK6, A5PJD3, A6H7B4, A6NEV1, A6NGY1, A6NHS1, A6QP24, A8MUA0, A8MUI8, A8MV72, A8MX80, A8MYA2, D3ZAQ5, O60393, P0C1T1, P0DL12, P43359, Q0KK55, Q0VD86, Q1RN00, Q32LI3, Q3UN58, Q3ZCQ2, Q5M831, Q5M844, Q66H53, Q68US1, Q6AYA8, Q6DIA7, Q6K1E7, Q6PE65, Q6ZW13, Q80VY2, Q8BII1, Q8IY42, Q8N9G6, Q8NA77, Q8TDR4
Diamond homologs: Q66H17, Q8C5V0, Q96LK8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
706 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:45255113:A:AC | donor_gain | 1.0000 |
| 17:45255114:C:CC | donor_gain | 1.0000 |
| 17:45255114:CT:C | donor_gain | 1.0000 |
| 17:45255118:T:TA | donor_gain | 1.0000 |
| 17:45254509:CTGAG:C | acceptor_gain | 0.9900 |
| 17:45255114:CTCTT:C | donor_gain | 0.9900 |
| 17:45255127:C:A | donor_gain | 0.9900 |
| 17:45262033:T:A | donor_gain | 0.9900 |
| 17:45262003:CCTG:C | donor_gain | 0.9800 |
| 17:45262005:TGTC:T | donor_gain | 0.9800 |
| 17:45262012:C:CA | donor_gain | 0.9800 |
| 17:45255109:A:AC | donor_gain | 0.9700 |
| 17:45255110:C:CC | donor_gain | 0.9700 |
| 17:45255110:CTCA:C | donor_gain | 0.9700 |
| 17:45255244:T:TA | donor_gain | 0.9700 |
| 17:45256070:CCAG:C | acceptor_gain | 0.9700 |
| 17:45256071:CAGC:C | acceptor_gain | 0.9700 |
| 17:45256416:C:CC | acceptor_gain | 0.9700 |
| 17:45262000:CCA:C | donor_loss | 0.9600 |
| 17:45262001:CAC:C | donor_loss | 0.9600 |
| 17:45262002:A:AC | donor_loss | 0.9600 |
| 17:45262003:CCT:C | donor_loss | 0.9600 |
| 17:45256377:T:TA | donor_gain | 0.9500 |
| 17:45256072:A:T | acceptor_gain | 0.9400 |
| 17:45256411:CATCT:C | acceptor_gain | 0.9400 |
| 17:45257129:A:AC | donor_gain | 0.9400 |
| 17:45257130:C:CC | donor_gain | 0.9400 |
| 17:45262004:C:G | donor_loss | 0.9400 |
| 17:45256074:C:CC | acceptor_gain | 0.9300 |
| 17:45256414:CT:C | acceptor_gain | 0.9300 |
AlphaMissense
2516 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:45255708:G:C | F158L | 0.985 |
| 17:45255708:G:T | F158L | 0.985 |
| 17:45255710:A:G | F158L | 0.985 |
| 17:45254460:A:G | F374S | 0.982 |
| 17:45254466:A:G | I372T | 0.980 |
| 17:45255709:A:G | F158S | 0.979 |
| 17:45255460:A:G | L241P | 0.972 |
| 17:45254466:A:C | I372S | 0.965 |
| 17:45254459:A:C | F374L | 0.964 |
| 17:45254459:A:T | F374L | 0.964 |
| 17:45254461:A:G | F374L | 0.964 |
| 17:45255448:G:T | A245E | 0.959 |
| 17:45262013:C:G | G2R | 0.957 |
| 17:45262013:C:T | G2R | 0.957 |
| 17:45262013:C:A | G2W | 0.955 |
| 17:45255709:A:C | F158C | 0.952 |
| 17:45255439:A:G | L248P | 0.950 |
| 17:45255672:G:C | S170R | 0.948 |
| 17:45255672:G:T | S170R | 0.948 |
| 17:45255674:T:G | S170R | 0.948 |
| 17:45255712:A:G | L157P | 0.948 |
| 17:45255176:C:A | G336W | 0.944 |
| 17:45255704:C:G | A160P | 0.941 |
| 17:45255683:A:G | S167P | 0.938 |
| 17:45254466:A:T | I372N | 0.936 |
| 17:45257190:A:G | C11R | 0.935 |
| 17:45255176:C:G | G336R | 0.933 |
| 17:45255176:C:T | G336R | 0.933 |
| 17:45257188:G:C | C11W | 0.926 |
| 17:45255451:A:G | F244S | 0.924 |
dbSNP variants (sampled 300 via entrez): RS1000251424 (17:45262135 CCTGTGATGTCGCCGCCT>C,CCTGTGATGTCGCCGCCTCTGTGATGTCGCCGCCT), RS1000335712 (17:45263553 A>G), RS1000888056 (17:45259066 C>G), RS1000894770 (17:45255500 G>A,C,T), RS1000968958 (17:45261028 C>A,G), RS1001000272 (17:45261152 G>A), RS1001263320 (17:45255183 G>A), RS1001323360 (17:45258911 C>T), RS1001354952 (17:45258871 A>G), RS1002193172 (17:45260572 C>T), RS1002329179 (17:45263895 T>G), RS1002885821 (17:45261781 A>C,G), RS1002981396 (17:45263721 T>A,C,G), RS1003012080 (17:45264083 C>T), RS1004040013 (17:45254197 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004412_12 | Craniofacial microsomia | 9.000000e-06 |
| GCST005830_40 | Hand grip strength | 3.000000e-08 |
| GCST006661_255 | Male-pattern baldness | 2.000000e-22 |
| GCST006950_29 | Feeling worry | 3.000000e-11 |
| GCST008916_39 | Asthma | 8.000000e-12 |
| GCST009720_68 | Asthma | 2.000000e-11 |
| GCST009798_36 | Asthma | 2.000000e-10 |
| GCST010042_26 | Asthma | 9.000000e-14 |
| GCST010043_35 | Asthma | 8.000000e-15 |
| GCST010396_262 | Gut microbiota (bacterial taxa, hurdle binary method) | 3.000000e-07 |
| GCST90002388_500 | Lymphocyte count | 2.000000e-09 |
| GCST90002407_139 | White blood cell count | 4.000000e-10 |
| GCST90014325_65 | Asthma | 2.000000e-10 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006941 | grip strength measurement |
| EFO:0009589 | worry measurement |
| EFO:0007874 | gut microbiome measurement |
| EFO:0004587 | lymphocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | increases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): craniofacial microsomia